Innate Pharma SA
SWB:IDD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
P
|
Panasonic Holdings Corp
SWB:MAT1
|
JP |
|
P
|
PT Menthobi Karyatama Raya Tbk
IDX:MKTR
|
ID |
|
Nihon Parkerizing Co Ltd
TSE:4095
|
JP |
|
Enact Holdings Inc
NASDAQ:ACT
|
US |
|
E
|
Esso Thailand PCL
SET:ESSO
|
TH |
|
A
|
AVIC Industry Finance Holdings Co Ltd
SSE:600705
|
CN |
Wall St Price Targets
IDD Price Targets Summary
Innate Pharma SA
According to Wall Street analysts, the average 1-year price target for IDD is 5.445 EUR with a low forecast of 4.535 EUR and a high forecast of 6.496 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IDD's stock price target?
Price Target
5.445
EUR
According to Wall Street analysts, the average 1-year price target for IDD is 5.445 EUR with a low forecast of 4.535 EUR and a high forecast of 6.496 EUR.
What is the Revenue forecast for Innate Pharma SA?
Projected CAGR
92%
Over the last 14 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 7 years is 92%.
What is the Gross Profit forecast for Innate Pharma SA?
Projected CAGR
1 086%
The compound annual growth rate for Gross Profit over the next 3 years is 1 086%.
